Literature DB >> 28436979

Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patient.

J Yu1, Y Hu1, C Pu2, Z Liang1, Q Cui3, H Zhang1, Y Luo1, J Shi1, A Jin1, L Xiao2, Z Wu2, H Huang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28436979     DOI： 10.1038/bmt.2017.64

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  Isolated testicular relapse after allo-SCT in boys with ALL: outcome without second transplant.

Authors:  V A Bhadri; M R McGregor; N C Venn; N Hackenberg; S J Russell; M D Norris; M Haber; R Sutton; G M Marshall
Journal:  Bone Marrow Transplant       Date:  2009-06-22       Impact factor: 5.483

2.  T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.

Authors:  Yi Luo; Haowen Xiao; Xiaoyu Lai; Jimin Shi; Yamin Tan; Jingsong He; Wanzhuo Xie; Weiyan Zheng; Yuanyuan Zhu; Xiujin Ye; Xiaohong Yu; Zhen Cai; Maofang Lin; He Huang
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

3.  Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

Authors:  Nathalie Dhédin; Anne Huynh; Sébastien Maury; Reza Tabrizi; Kheira Beldjord; Vahid Asnafi; Xavier Thomas; Patrice Chevallier; Stéphanie Nguyen; Valérie Coiteux; Jean-Henri Bourhis; Yosr Hichri; Martine Escoffre-Barbe; Oumedaly Reman; Carlos Graux; Yves Chalandon; Didier Blaise; Urs Schanz; Véronique Lhéritier; Jean-Yves Cahn; Hervé Dombret; Norbert Ifrah
Journal:  Blood       Date:  2015-01-13       Impact factor: 22.113

Review 4.  CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.

Authors:  Jae H Park; Mark B Geyer; Renier J Brentjens
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

5.  International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget; Hervè Dombret; Jose-Maria Ribera; Adele K Fielding; Anjali Advani; Renato Bassan; Victoria Chia; Michael Doubek; Sebastian Giebel; Dieter Hoelzer; Norbert Ifrah; Aaron Katz; Michael Kelsh; Giovanni Martinelli; Mireia Morgades; Susan O'Brien; Jacob M Rowe; Julia Stieglmaier; Martha Wadleigh; Hagop Kantarjian
Journal:  Haematologica       Date:  2016-09-01       Impact factor: 9.941

6.  Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Authors:  Partow Kebriaei; Harjeet Singh; M Helen Huls; Matthew J Figliola; Roland Bassett; Simon Olivares; Bipulendu Jena; Margaret J Dawson; Pappanaicken R Kumaresan; Shihuang Su; Sourindra Maiti; Jianliang Dai; Branden Moriarity; Marie-Andrée Forget; Vladimir Senyukov; Aaron Orozco; Tingting Liu; Jessica McCarty; Rineka N Jackson; Judy S Moyes; Gabriela Rondon; Muzaffar Qazilbash; Stefan Ciurea; Amin Alousi; Yago Nieto; Katy Rezvani; David Marin; Uday Popat; Chitra Hosing; Elizabeth J Shpall; Hagop Kantarjian; Michael Keating; William Wierda; Kim Anh Do; David A Largaespada; Dean A Lee; Perry B Hackett; Richard E Champlin; Laurence J N Cooper
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

7.  Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.

Authors:  Yongxian Hu; Zhao Wu; Yi Luo; Jimin Shi; Jian Yu; Chengfei Pu; Zuyu Liang; Guoqing Wei; Qu Cui; Jie Sun; Jing Jiang; Jue Xie; Yamin Tan; Wanmao Ni; Jifang Tu; Jinping Wang; Aiyun Jin; Hao Zhang; Zhen Cai; Lei Xiao; He Huang
Journal:  Clin Cancer Res       Date:  2016-12-30       Impact factor: 12.531

8.  Isolated primary testicular B lymphoblastic lymphoma: an unusual presentation.

Authors:  Alejandro V Garcia; Bachir Alobeid; Jocelyn M Traina; Susie S Chen; Michael A Weiner; William Middlesworth
Journal:  J Pediatr Hematol Oncol       Date:  2013-03       Impact factor: 1.289

9.  Continued complete remission without systemic therapy for isolated testicular relapse after bone marrow transplantation in a boy with acute lymphoblastic leukemia.

Authors:  Yuichi Kodama; Yasuhiro Okamoto; Osamu Ijichi; Yuichi Shinkoda; Takuro Nishikawa; Takayuki Tanabe; Takako Yoshioka; Yukie Tashiro; Hiroyuki Mougi; Yoshifumi Kawano
Journal:  Pediatr Transplant       Date:  2009-11-26

10.  Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.

Authors:  Yongxian Hu; Jie Sun; Zhao Wu; Jian Yu; Qu Cui; Chengfei Pu; Bin Liang; Yi Luo; Jimin Shi; Aiyun Jin; Lei Xiao; He Huang
Journal:  J Hematol Oncol       Date:  2016-08-15       Impact factor: 17.388
View more
  1 in total

1.  Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cells.

Authors:  Semjon Willier; Johannes Raedler; Franziska Blaeschke; Dana Stenger; Montserrat Pazos Escudero; Florian Jurgeleit; Thomas G P Grünewald; Vera Binder; Irene Schmid; Michael H Albert; Armin Wolf; Tobias Feuchtinger
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.